# Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement

> **NCT05789030** · NA · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Autoimmune Diseases

## Interventions

- **DRUG:** glucocorticoid plus iguratimod
- **DRUG:** glucocorticoid plus leflunomide

## Key facts

- **NCT ID:** NCT05789030
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05789030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05789030, "Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05789030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*